Back to top
more

PetMed Express (PETS)

(Delayed Data from NSDQ)

$3.67 USD

3.67
241,458

-0.14 (-3.67%)

Updated Aug 2, 2024 04:00 PM ET

After-Market: $3.74 +0.07 (1.91%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (64 out of 251)

Industry: Internet - Commerce

Better trading starts here.

Zacks News

Amazon CEO Tops Forbes Rich List, Shares Hit 52-Week High

Amazon (AMZN) attains 52-week high on AWS strength and diversified presence. Meanwhile, CEO Jeff Bezos tops Forbes Rich List for the first time.

    Amedisys (AMED) Strong on Buyouts & Solid Personal Care Unit

    Amedisys (AMED) forges ahead with buyouts to boost capacity and geographical presence.

      Abbott Gets FDA Nod for Masters HP 15mm, Boosts Portfolio

      Abbott (ABT) adopts initiatives to strengthen the Structural Heart business within the Medical Device segment.

        Allscripts (MDRX) Launches Avenel to Revamp EHR Platform

        Allscripts' (MDRX) innovation team comes up with a user-friendly application, Avenel, to aid patients and clinicians through EHR.

          Chimerix Q4 Loss Narrower Than Expected, Revenues Exceed

          Chimerix (CMRX) makes progress in Q4 through advancement with lead product candidate, brincidofovir. Revenues decline from lower reimbursable expenses regarding BARDA developmental contract.

            Boston Scientific Acquires EMcision, Boosts Endoscopy Unit

            Boston Scientific (BSX) adopts initiatives to strengthen the Endoscopy business.

              Abaxis Banks on Strong Veterinary Business Amid Margin Woes

              Abaxis' (ABAX) strong performance in Veterinary consumables drives growth. Weak gross and operating margin scenario is a concern.

                3 Reasons Why You Should Invest in athenahealth (ATHN) Stock

                athenahealth (ATHN) rides on solid fourth-quarter results and strong fundamentals.

                  Here's Why Teleflex Has Been Losing Ground Since Q4 Earnings

                  Teleflex's (TFX) contracted Q4 adjusted operating margin is discouraging.

                    BioTelemetry (BEAT) Beats Q4 Earnings and Revenue Estimates

                    BioTelemetry (BEAT) sees strong Q4 results, courtesy of solid acquisitions and promising performance by the MCT platform.

                      eBay's (EBAY) Marketplace is Expected to Do Well in 2018

                      eBay (EBAY) is making all efforts to improve its Marketplace business.

                        JD.com (JD) Q4 Earnings Miss Estimates, Revenues Improve Y/Y

                        JD.com's (JD) fourth-quarter earnings are impacted by higher spending in growth areas including fulfillment centers and increasing competition from Alibaba.

                          Bio-Rad (BIO) Q4 Earnings Improve Y/Y, Revenues Top Mark

                          Bio-Rad's (BIO) strong sales in Q4 ride high on a robust performance at Life Science product lines.

                            OPKO Health (OPK) Q4 Earnings Decline Y/Y, Margins Down

                            OPKO Health (OPK) posts lackluster Q4 numbers due to rising operating expenses owing to investments associated with the launch of RAYALDEE and consistent investments in the pharmaceutical pipeline.

                              DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q4

                              Strong performance at Dental & Healthcare Consumables segment drives DENTSPLY's (XRAY) Q4 sales.

                                Patterson Companies (PDCO) Misses on Q3 Earnings, Cuts View

                                Lower sales and gross-margin compression mars Patterson Companies' (PDCO) results in Q3.

                                  Alarm.com (ALRM) Q4 Earnings Top Estimates, Issues 2018 View

                                  Alarm.com (ALRM) reports strong fourth-quarter results on the back of higher SaaS and license revenues, and portfolio expansion.

                                    Masimo (MASI) Beats on Q4 Earnings & Revenues, View Positive

                                    Strong performance in Product revenues drove Masimo's (MASI) fourth-quarter 2017 results.

                                      DexCom (DXCM) Surpasses Earnings & Revenue Estimates in Q4

                                      DexCom (DXCM) rides high on strength in all segments in Q4.

                                        Wright Medical (WMGI) Beats Q4 Earnings & Revenue Estimates

                                        Wright Medical (WMGI) delivers promising Q4 results on the back of strength in its flagship Upper Extremities segment, despite declining international revenues of the Lower Extremities.

                                          Amedisys (AMED) Q4 Earnings Miss, Revenues Beat Estimates

                                          Amedisys (AMED) registers strong growth across all segments in Q4.

                                            Penumbra (PEN) Posts Earnings in Q4, Revenues Top Estimates

                                            Penumbra (PEN) sees strong growth across all geographical regions and product lines in Q4.

                                              Inogen (INGN) Beats Earnings and Revenue Estimates in Q4

                                              Inogen (INGN) reports impressive Q4 financial results on the back of strong business-to-business and direct-to-consumer sales growth.

                                                Integra LifeSciences (IART) Beats on Q4 Earnings & Revenues

                                                Integra LifeSciences's (IART) solid Q4 revenue growth was primarily driven by high organic revenues and better-than-expected performance by the recently-acquired businesses.

                                                  Booking Holdings (BKNG) Beats on Q4 Earnings & Revenues

                                                  Booking Holdings' (BKNG) fourth-quarter results are driven by significant contributions from investments in people, systems and marketing.